Literature DB >> 22999538

Differential effects of botulinum neurotoxin A on bladder contractile responses to activation of efferent nerves, smooth muscles and afferent nerves in rats.

Ryosuke Takahashi1, Takakazu Yunoki, Seiji Naito, Naoki Yoshimura.   

Abstract

PURPOSE: To determine the mechanisms of botulinum neurotoxin A (Metabiologics, Madison, Wisconsin) induced inhibition of bladder activity we examined the effect of botulinum neurotoxin A on detrusor contractile responses to the activation of L-type voltage-gated Ca(2+) channels, and efferent and afferent nerve terminals in the rat bladder.
MATERIALS AND METHODS: Rat bladder strips were incubated for 3 hours with different concentrations of botulinum neurotoxin A (0.3 to 100 nM). We examined the effect of botulinum neurotoxin A on detrusor contractility in response to activation of L-type voltage-gated Ca(2+) channels, and efferent and afferent nerve terminals induced by 70 mM KCl, electrical field stimulation and 1 μM capsaicin, respectively.
RESULTS: Botulinum neurotoxin A inhibited electrical field stimulation induced contractions at a concentration of 10 nM or higher. The maximal inhibition at 100 nM was 70% compared to that of control strips. KCl induced contractions, which were sensitive to nifedipine, were significantly inhibited by incubation with botulinum neurotoxin A at a concentration of 3 nM or higher. Maximal inhibition at 100 nM was 30% compared to that of control strips. Capsaicin induced contractions were not inhibited by 3-hour incubation but they were significantly inhibited by overnight incubation with 100 nM botulinum neurotoxin A (30% compared to control strips). Carbachol induced contractions were not altered by incubation with botulinum neurotoxin A.
CONCLUSIONS: The order of inhibitory potency of botulinum neurotoxin A was efferent nerve terminals >L-type voltage-gated Ca(2+) channels >afferent nerve terminals. Since the inhibitory effects on L-type voltage-gated Ca(2+) channels and efferent nerve terminals were observed at similar botulinum neurotoxin A concentrations, the inhibitory effect of botulinum neurotoxin A on L-type voltage-gated Ca(2+) channels may have an important role in regulating and stabilizing bladder activity.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22999538     DOI: 10.1016/j.juro.2012.07.001

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  OnabotulinumtoxinA (Botox(®)): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injury.

Authors:  Mark Sanford
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

2.  Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder.

Authors:  Pradeep Tyagi; Mahendra Kashyap; Naoki Yoshimura; Michael Chancellor; Christopher J Chermansky
Journal:  J Urol       Date:  2016-11-18       Impact factor: 7.450

3.  Bladder smooth muscle strip contractility as a method to evaluate lower urinary tract pharmacology.

Authors:  F Aura Kullmann; Stephanie L Daugherty; William C de Groat; Lori A Birder
Journal:  J Vis Exp       Date:  2014-08-18       Impact factor: 1.355

Review 4.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

5.  Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium.

Authors:  Ann T Hanna-Mitchell; Amanda S Wolf-Johnston; Stacey R Barrick; Anthony J Kanai; Michael B Chancellor; William C de Groat; Lori A Birder
Journal:  Neurourol Urodyn       Date:  2013-10-26       Impact factor: 2.696

6.  Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?

Authors:  Amélie Huynh Le Maux; Bernadette Pignol; Delphine Behr-Roussel; Jean-Luc Blachon; Pierre-Etienne Chabrier; Sandrine Compagnie; Philippe Picaut; Jacques Bernabé; François Giuliano; Pierre Denys
Journal:  Toxins (Basel)       Date:  2015-12-17       Impact factor: 4.546

7.  Botulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies.

Authors:  Jacquie Maignel-Ludop; Marion Huchet; Johannes Krupp
Journal:  Pharmacol Res Perspect       Date:  2017-01-31

8.  New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA.

Authors:  Karl-Erik Andersson
Journal:  Ther Clin Risk Manag       Date:  2013-04-18       Impact factor: 2.423

9.  Development of an in vitro model to measure bioactivity of botulinum neurotoxin A in rat bladder muscle strips.

Authors:  Janneke I M van Uhm; Goedele M A Beckers; Willem J van der Laarse; Eric J H Meuleman; Albert A Geldof; Jakko A Nieuwenhuijzen
Journal:  BMC Urol       Date:  2014-05-15       Impact factor: 2.264

10.  Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.

Authors:  Mark Elliott; Jacquie Maignel; Sai Man Liu; Christine Favre-Guilmard; Imran Mir; Paul Farrow; Fraser Hornby; Sandra Marlin; Shilpa Palan; Matthew Beard; Johannes Krupp
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.